Read more about how low testosterone levels are linked to ‘extreme’ disease progression in patients with prostate cancer ...

The 20-year story of how a strategy of active surveillance of low-risk papillary thyroid microcarcinomas (PMCs) became accepted at a hospital in Japan, where the practice first gained recognition, has ...

A cancer diagnosis is serious, but immediately starting treatment sometimes isn't the best course of action. ljubaphoto/E+ via Getty Images Although about 1 in 8 men in the U.S. will be diagnosed with ...

Outranked only by skin cancer, prostate cancer is the second most common cancer in men in the U.S. Although one in every eight American men will be diagnosed with prostate cancer at some point, an ...

If your cancer is not causing any symptoms, is growing slowly, or is small and only in your prostate, your physician may suggest active surveillance or watchful waiting instead of treatment. Active ...

Active surveillance of small renal masses appears to be safe, but if intervention does become necessary, what should trigger it? "We now know that with at least 10 years of data that active ...

Active surveillance offers a conservative yet increasingly validated approach to managing small renal masses. By closely monitoring these lesions through regular imaging and clinical assessments, ...

A new study finds men with prostate cancer are increasingly choosing active surveillance instead of invasive treatment such as surgery or radiation. With active surveillance, if tests show that the ...

Active surveillance adoption for low-risk prostate cancer increased from 54% to 84% between 2015 and 2021. A commercial payer's payment incentive program showed no significant impact on increasing ...

Although most prostate cancer specialists believe active surveillance to be effective and underused, fewer endorse active surveillance than other therapies for low-risk prostate cancer, according to a ...

Please provide your email address to receive an email when new articles are posted on . From 2010 to 2018, rates of active surveillance/watchful waiting in the U.S. increased from 16.4% to 59.9% for ...

Jinping Xu receives funding from the American Cancer Society and the U.S. Department of Defense. Although about 1 in 8 men in the U.S. will be diagnosed with prostate cancer during their lifetime, ...